Sei Investments Co. Acquires 7,295 Shares of Solventum Co. (NYSE:SOLV)

Sei Investments Co. raised its stake in Solventum Co. (NYSE:SOLV - Free Report) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,638 shares of the company's stock after acquiring an additional 7,295 shares during the quarter. Sei Investments Co.'s holdings in Solventum were worth $2,487,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of SOLV. Modus Advisors LLC bought a new stake in shares of Solventum during the 4th quarter valued at $25,000. Stonebridge Financial Group LLC acquired a new stake in shares of Solventum in the 4th quarter valued at about $26,000. Crews Bank & Trust bought a new stake in shares of Solventum in the fourth quarter valued at about $32,000. Synergy Asset Management LLC acquired a new position in shares of Solventum during the fourth quarter worth about $35,000. Finally, Spire Wealth Management bought a new position in shares of Solventum during the fourth quarter worth about $37,000.

Analysts Set New Price Targets

SOLV has been the topic of several research reports. The Goldman Sachs Group boosted their target price on Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research note on Monday, March 3rd. Bank of America increased their target price on shares of Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a report on Wednesday, February 26th. Piper Sandler lifted their price target on shares of Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a research note on Friday, February 28th. Mizuho increased their price objective on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. Finally, Morgan Stanley lifted their target price on Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research report on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Solventum has an average rating of "Hold" and a consensus target price of $79.86.

Solventum Stock Performance

SOLV stock traded up $5.60 during mid-day trading on Wednesday, hitting $68.61. 2,305,470 shares of the company were exchanged, compared to its average volume of 1,350,715. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $85.92. The business has a 50 day simple moving average of $74.52 and a 200-day simple moving average of $71.75. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The stock has a market capitalization of $11.87 billion and a PE ratio of 24.95.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.